A systematic review and meta-analysis published in Archives of Dermatological Research quantifies the prevalence of sleep disturbances among patients with atopic dermatitis, highlighting substantial disease...
A new evaluation of an emergency department skin and soft tissue infection protocol using rapid methicillin-resistant Staphylococcus aureus polymerase chain reaction wound testing explores whether...
The FDA has granted full approval for the use of brexucabtagene autoleucel in adults with relapsed or refractory mantle cell lymphoma, based on confirmatory ZUMA-2 data.
A double-blind, placebo-controlled cross-over trial published in BMC Gastroenterology evaluated whether 12 g/day of chicory inulin improves bowel habits, patient-reported outcomes, and gut microbiota...
At AAEM26, a session examined limitations of SIRS-based sepsis screening, highlighting patient populations at risk for missed diagnosis and adjunctive strategies for earlier identification.
New reports detail the spread of SARS-CoV-2 variant BA.3.2, Long COVID disability burden, sarbecovirus cross-immunity, and how stacked outpatient risk factors shape severe COVID-19 outcomes.
On March 25, the FDA has approved relacorilant (Lifyorli), in combination with nab-paclitaxel for adults with platinum-resistant ovarian and related gynecologic cancers who have received prior systemic...
A large real-world cohort analysis presented at the American College of Cardiology’s Annual Scientific Session suggests catheter ablation may be associated with improved survival and reduced stroke risk...
